Company or ticker...

Dianthus Therapeutics

Dianthus develops antibody therapies for severe autoimmune diseases.

Ticker

M. Cap

PS

PE

YTD

10MA

20MA

50MA

200MA

DNTH

5.2B

3,901.8

n/a

131.94%

Key Facts

M. Cap

PS

PE

YTD

5.2B

3,901.8

n/a

131.94%

10MA

20MA

50MA

200MA

$DNTH